Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13

690 views

Published on

LDI Charles Leighton, MD Memorial Lecture

  • Be the first to comment

  • Be the first to like this

High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13

  1. 1. E EM Q AS IR A M R OM High Value Cost Conscious g IS S IO N F RM Care: Is it Rationing or EN PE T IT Rational C O?WR R i l Care?R PRI O UT H IT W E UT Qaseem, MD PhD MHA Amir Qaseem MD, PhD, MHA, FACP B T RI IS Director, Clinical Policy, American College of Physicians D O R Chair, Guidelines International Network RE S HA NOTDO
  2. 2. E EM Q AS IR Conflicts of Interest A M R OM F N  Financial: SIO IS  Employee of the American CollegeMof Physicians ER P  No other financial conflicts TE N T RI W OR RI  Non-financial: UT P OH  Guidelines International Network IT W T E  Institute ofUMedicine B T RI  Centers for Disease Control and Prevention IS D OR RE S HA NOTDO
  3. 3. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  4. 4. E EM AS Cost of Health Care in the US A M IR Q R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA T NO CMS, Office of the Actuary, National Health Statistics GroupDO
  5. 5. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOT Reinhardt, NY Times, 12/24/2010.DO
  6. 6. E EM AS Diagnostic Imaging Studies in 6 LargeMIR Q A Integrated Health Care System R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOT Smith-Bindman R et al. JAMA. 2012;307:2400-2409.DO
  7. 7. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  8. 8. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  9. 9. E EM AS Overtreatment A M IR Q R OM F N IO  Unnecessary treatment IS S RM  End of life care PE T EN  Excessive use of antibiotics R IT W  Generic vs non-generics OR or higher-priced PRI T services vs l i lessHexpensive alternates OU i lt t IT W UTE R IB ST DI OR RE S HA NOTDO
  10. 10. E EM AS End of Life: Where Do Patients AMIR Q Die? OM FR N O  Hospital: ~53% 53% SI IS E RM P  Nursing home: ~24% TEN R IT W  Home: ~24% OR PRI  Data f D t from UT t di other studies: th HO IT W T E  Survey y data: 60-80% of people want to die U p p B at home T RI IS D OR  ~22% 22% RE of people die in an ICU S HA NOT Gruneir A et al. Med Care Res Rev. 2007; 64:351DO
  11. 11. E EM AS The Cost of Wasted Resources and A M IR Q Unnecessary Diagnostic Testing OM FR N O SI IS E RM  Current waste: an estimated N$750 billion loss P in 2009 (IOM 2012) T TE RI W  Inappropriate diagnostic O R testing (i.e. testing PRI that is overused or OU Tmisused) is estimated to H IT cost approximately $210 billion per year (10% W E UT of annual Ihealth care costs) B T R (PriceWaterhouse (www.pwc.com) D IS OR RE S HA NOTDO
  12. 12. E EM AS Excess Costs Domain EstimatesAMIR Q (30% of Health Care Costs) N FR OM O Cost in Billions of $$$ Cost in Billions of $$$ SI IS E RM P Unnecessary Services  $75  TEN ($210 B) $210  R IT Inefficiently Delivered  $55  W OR Services ($130 B) PRI Excess Administrative  $105  $105 O UT Costs ($190 B) Costs ($190 B) H Excessive Pricing ($105 B) IT W U TE $130  $130 Missed Prevention  R IB Opportunities ($55 B) I ST$190  Fraud ($75 B) D OR RE S HA NOT The Healthcare Imperative 2010 IOMDO
  13. 13. E EM AS According to the IOM report A M IR Q R OM F ON  If banking worked like health care, ATM transactions g , SI IS would take days. RM PE  T EN If home building were like health care, carpenters, electricians and plumbers would work f l ti i d l b ld R IT k from diffdifferent t W blueprints. OR PRI  If shopping were like health care, prices would not be T posted and could vary H OUwidely within the same store, IT W depending on who was paying. E UT  If airline t RIBl were lik h lth care, i di id l pilots i li travel like health individual il t T would beISD free to design their own preflight safety checks — or OR perform one at all. E not p AR SH NOTDO
  14. 14. E EM AS Are We Willing (and Able) to AMIR Q Address the Problem? OM FR N O SI IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  15. 15. E EM AS It Is Our Ethical and ProfessionalIR AM Q Responsibility to Control Cost! OM FR N O SI From Medical Professionalism in the New Millennium: A IS RM PE Physician Charter (ABIM-F, ACP-F, EFIM) EN “While meeting the needs of individual patients, physicians T are required to provide health care R IT that is based on the W OR wise and cost-effective management of limited clinical resources.” P RI T OU “The physician’s professional responsibility for appropriate H IT allocation of resources requires scrupulous avoidance of W E p UT superfluous tests and p procedures. The provision of p R IB unnecessary services not only exposes one’s patients to ST DI avoidable harm and expense but also diminishes the OR resources available for others.”others. E AR SH T OAnn Intern Med. 2002; 136:243-246 NDO
  16. 16. E EM AS Physician Controlled Costs A M IR Q R OM F N  Unnecessary testing SIO IS and treatment $210B RM PE  Inefficiently delivered y T EN R IT care $130B W OR RI  Missed prevention T P p opportunities $55B H OU IT W  Total = $395B E UT B T RI S DI OR RE S HA NOTDO
  17. 17. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  18. 18. E EM AS Why is there an overused or A M IR Q misuse? R OM F N  Lack of  IO Clinical performance S IS guidance/guidelines measures RM PE T EN  Lack of knowledge  RIT Discomfort with W R diagnostic uncertainty Insecurity about IO  PR clinical skills li i l kill O UT  Discontinuity of care Di ti it f H IT W  Patient expectations E  Inadequate time with BUT RI patients  Fear of ST Imalpractice D O R E  Habits  PARPersonal gainl i S H T NODO
  19. 19. E EM AS Financial Incentives Can Drive AMIR Q Behavior OM FR N Stress Testing Within 30 Days of Outpatient Visit After O SI Coronary R C Revascularization (%) l i i IS M P ER EN 30 T T 25 RI W OR RI 20 P 15 O UT Tech+Prof H Fee IT 10 W Prof Fee UTE Only 5 R IB No Billing ST 0 DI R ONo Symptoms CABG PCI Overall RE Symptoms S HA T NO BR et al. JAMA. 2011; 306:1993 ShahDO
  20. 20. E EM AS Financial Incentives Can Drive AMIR Q Behavior OM FR N O  S SI A review of ownership of nuclear Imyocardial perfusion studies among MedicareRM patients: PE T EN  cardiologists cardiologists’ offices increased 215% between T RI 1998 and 2006, W O R RI  radiologists and other physicians increased 32% P T OU and 181% respectively H IT W UTE R IB ST DI OR RE S HA T NO DC et al. J Am Coll Radiol. 2009;6(6):437-441 LevinDO
  21. 21. E EM AS Financial Incentives Can Drive AMIR Q Behavior OM FR N O  Self employed Self-employed urologists (who owned office- SI office IS based imaging equipment) were RM2 to 5 times PE g ITgT EN more likely to order imaging for a variety of y y R W urinary conditions compared with those OR urologists who wereP in g RI employment based p y T OU practice modelsH(salaried and not owning IT equipment)UTE W B T RI S DI OR RE S HA T NO Hollingsworth JM et al. J Urol. 2010;184(6):2480-2484DO
  22. 22. E EM AS Physicians Lack Understanding About BenefitIR Q A M of S f Screening T i Tests OM FR N S IO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA OT Wegwarth O et al. Ann Intern Med 2012;156:340-349 NDO
  23. 23. E EM AS Ovarian Cancer Screening: A M IR Q What are the Recommendations? OM FR N O  D SI Routine screening: “D” grade (USPSTF) IS E RM  High risk (based on family Ehx.): referral for N P genetic counseling and RITT BRCA testing W (USPSTF and ACOG) RI O R P T  +BRCA1 or +BRCA2: candidate f risk- BRCA1 BRCA2 H OU did t for i k IT reducing surgery, not screening (Soc. Gyn. E W UT Onc.) Onc ) RIB T D IS O R E AR SH OT Baldwin L-M, et al. Ann Intern Med. 2012; 156: 182. NDO
  24. 24. E EM AS Ovarian Cancer Screening: A M IR Q What Do Physicians Think? N FR OM O  1/3 say transvaginal ultrasound or SI IS RM Ca-125 is an effectiveEscreening PE N T IT test t t W R OR  Study used case g y PRI vignettes T OU  65% offered ITH screening to medium-risk W woman UT E B T RI  29%Soffered screening I to low-risk woman D O R E AR SH OT Baldwin L-M, et al. Ann Intern Med. 2012; 156: 182. NDO
  25. 25. E EM AS Defensive Medicine A M IR Q R OM F N IO  $45.6 $45 6 billion in 2008 for hospital and IS S RM 29: 1569-1577) physician spending (Mello et al, Health Affairs 2010; PE EN  Most common forms (Studdert et T JAMA 2005;293: 2609-2617) RI T al al, 2609 2617) W  Over-ordering of diagnostic tests O R PRI  Unnecessary referrals T H OU  Avoidance of WIT high-risk patients U TE R IB ST DI OR RE S HA NOTDO
  26. 26. E EM AS Defensive Medicine A M IR Q R OM F N IO  “when doctors order tests procedures or when tests, procedures, IS S visits, or avoid certain high-risk patients or RM PE p procedures, p , primarily ( ITT y (but not EN solely) because y) R W of concern about malpractice liability --- US OR g PRI Congress Office ofT Technology Assessment gy H OU  Says nothing about the damages that patient IT W T E could incurUfrom excess or unnecessary y B screening T RI IS D OR RE S HA NOTDO
  27. 27. E EM AS Do Physicians Agree That A M IR Q Healthcare is Overused? R OM F N IO Survey of primary care physiciansISS E RM  42% believe patients in theirPown practice T EN are receiving too much care (vs 6% who R IT (vs. W say “too little”) O R PRI  Perceived factors T leading to overuse OU H IT  Malpractice W E concerns: 76% UT  Cli i RIB f Clinical performance measures: 52% l S T DI  Inadequate time to spend with patients: 40% OR RE S HA NOT Sirovich B et al. Arch Intern Med. 2011; 171:1582-1585DO
  28. 28. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA OT N Owens D; Qaseem A et al. Ann Intern Med. 2011; 154:174-180DO
  29. 29. E EM AS Value = Benefits, Harms, Costs AMIR Q R OM F  Value = benefit / (cost + harm) SIO N IS  Cost ≠ Value RM PE EN  Cost includes cost of testTand downstream T RI costs, benefits and harms W O R PRI  High cost interventions may provide good T H OU value because they are highly beneficial W IT E Low cost T  Low-costUinterventions may have little or B T RI no value if they provide little benefit or D IS R increase downstream costs. R E O S HA OT NOwens D; Qaseem A et al. Ann Intern Med. 2011; 154:174-180DO
  30. 30. E EM AS Benefit, Cost, and Value A M IR Q R OM High Benefit F Low Benefit N O SI IS M High Anti-retroviral ER Routine MRI for low P therapy for HIV N backTpain E Cost T RI W Value: high O RValue: low PRI O UT Low HIV screening H Annual pap smears IT Cost W UTE R IB T Value: high Value: low D IS OR RE S HA OT N Owens D; Qaseem A et al. Ann Intern Med. 2011; 154:174-180DO
  31. 31. E EM AS Value Measurement: Quality MIR Q A Adjusted Life Years (QALYs)ROM F N IO  An important metric for measuring health S IS RM benefits by taking into accountEboth length P N and quality of life q y TE ITR W I OR PR  Allows for comparison of interventions UT HO IT between different specialities (compare W E UT cancer treatments with cardiovascular B T RI treatments) D IS OR RE S HA NOTDO
  32. 32. E EM AS Four interventions, A, B, C, D A M IR Q R OM F A is better and cheaper ND IO than S IS E RM P TEN R IT B is better than A b i b h but W more expensive OR PRI O UT H IT W UTE C is better than B but IB more expensive T R S DI OR RE S HA OT N Owens D; Qaseem A et al. Ann Intern Med. 2011; 154:174-180DO
  33. 33. E EM AS Cost-Effectiveness Threshold: MIR Cost- Q A How Much is Health Worth?ROM F N  Threshold depends on who is making the S IO IS decision and their willingness toPpay for better E RM health outcomes T EN R IT  National Health Service R in WUK $30,000-$50,000/ O QALY PRI T  No consensus in H USOU - citizens have been willing IT W to pay up to $109,000/QALY, most US decision E BUT k T RI id makers consider interventions that cost l i i h less than h S DI $50,000-$60,000/QALY high value OR RE S HA T NODO
  34. 34. E EM AS QALY Examples A M IR Q OM Intervention Cost Effectiveness N FR Ratio O SI Prevention M P ti Measures IS RM High intensity smoking prevention $190/QALY E P N T TE Screening 60 y o for Diabetes $ RI $25,738/QALY W O R RI Treatments for existing conditions P T ART for HIV OU $29,000/QALY I TH W Implantation of defibrillators $52,000/QALY U TE oIB Surgery in 70 y R male with Increased cost and worsens T prostate ca DIS health OR RE S HA T NO Cohen JT et al. N Engl J Med 2008;358:661-663DO
  35. 35. E EM AS How Can We Reduce A M IR Q Inappropriate Care? R OM F N IO  Develop guidance for physicians Iabout SS appropriate use of care, focusing RM initially on PE diagnostic testing g g T EN IT R  Assemble and integrateRevidence-based and W O RI consensus-based recommendations P  Ed Educate t UT t target audiences about areas of t HO di b t f IT overuse andEmisuse of care: W  Trainees IB UT (students, residents, and fellows) (students residents T R IS www.highvaluecarecurriculum.org D R  Practicing clinicians E O g R APatients SH NOTDO
  36. 36. E EM AS Key Features of Bringing Cost Consciousness IR Q A M into the T i i E i i h Training Environment OM FR N  Approach: focus on appropriate careS S IO rather than I saving money RM PE  Knowledge: understanding of EN T what helps h ti fl RIT patients vs. what is superfluous or even harms ti t W h patients OR PRI  Philosophy: recognition that more ≠ better T H OU  Faculty development: trainees mimic faculty IT behavior TE W U  R IB Assessment: of trainee knowledge and behavior ST  DI Regulation: cost consciousness in residency OR competency requirements RE S HA NOTDO
  37. 37. E EM AS Towards High-Value Cost-Conscious Care High- Cost- IR Q AM M Ocare  Ask appropriate questions at the point of FR N  Did the patient have this test previously? SIO IS  RM Will the result of this test change the care of the patient? PE T EN  R IT What are the probability and potential adverse W consequences of a false positive result? OR  Is the patient in potentialI danger in the short term if I do PR not perform thi t Ot? t f UT this test? H  Am I ordering W IT test primarily because the patient the wants it orUTEreassure the patient? to B  Observe T RIand provide feedback to trainees on D IS their O R provision of high value care- let them E AR H know if they are wasting resources! S NOTDO
  38. 38. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB IdentifiesIST clinical situations in which a screening or 37 D diagnostic test does not reflect high value care. R O RE S HA T OQaseem et al. Ann Intern Med. 2012; 156:147-149. NDO
  39. 39. E EM AS Overused Dx Tests A M IR Q R OM F  Screening for colorectal cancer in adults ON SI older than 75 y or in adults withRa life IS M PE expectancy of less than 10 yN T TE  Performing imaging studies RI in patients with W O R nonspecific low backRIpain P UT  Ordering routine O H preoperative laboratory IT W tests, including complete blood count, liver E UT chemistryIB TR tests, and metabolic profiles, in f S DI otherwise healthy patients undergoing OR l RE ti elective surgery HA S T NODO
  40. 40. E EM AS Overused Dx Tests A M IR Q R OM F N Performing brain imaging studies (CT Ior MRI) to IO  SS evaluate simple syncope in patients RM normal E with P findings on neurologic examination N T TE  Obtaining CT scans in a patient RI with pneumonia that W O R is confirmed by chest radiography in the absence of RI P complicating clinical U T radiographic features or H O  Performing imaging IT studies, rather than a high- W E DBUT sensitivity D-dimer measurement, as the initial dimer I diagnosticRtest in patients with low pretest probability IS T D of venous thromboembolism O R RE S HA NOTDO
  41. 41. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA T OChou R; Qaseem A; et al Ann Intern Med. 2011; 154:181-189 NDO
  42. 42. E EM AS Example of Healthcare Waste A M IR Q R OM F N IO  Patient with uncomplicated back pain without IS S any red flags RM PE EN  Total cost of workup and RITT treatment done in W this case (plain films, IMRI, physical therapy): O R PR $10,821.93 T H OU IT  Total cost of workup and treatment that would W E UT be recommended by ACP guideline : $908 IB R T DIS OR RE S HA NOTDO
  43. 43. E EM Q AS IR A M R OM F N SIO IS E RM P EN T  I addition t measure underuse of care, In dditi to RdIT f W need to develop evidence-based OR PRI T performance measures to assess use of low low- H OU value interventions IT W E UT  ServicesIBwhere harm exceeds the zero to R ST negligible benefit DI OR RE S HA T NO Baker D; Qaseem A et al. Ann Intern Med. 2013; 158DO
  44. 44. E EM AS Patient Education A M IR Q R OM  Shared-decision making N F O SI  Involve patients and their familiesS M I P ER  According to a recent IOM report: N E T  69 percent patients want th t ti t t WR ITi provider t t ll th their id to tell them OR the risks of the treatment options so they will know PRI how each might affect them T OU  53 percent wantHto know about each option’s cost IT W to themselves E and their family. BUT  47 percent T RI patients want their health care provider IS to OR D discuss the option of not pursuing a test or tE t Atreatment R t SH T OIOM 2012. Communicating with patients on health care evidence. NDO
  45. 45. E EM AS Patient Education A M IR Q R OM  Annals of Internal Medicine Summaries for N F O Patients SI IS RM http://www.acponline.org/clinical_informati PE T EN on/guidelines/ R IT W  ACP Foundation’s Health TiPS OR PRI T  Collaborations with consumer OU H IT organizations (e.g., Consumer Reports) W E that include BUT videos and educational T RI IS materials D OR RE S HA NOTDO
  46. 46. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB S T DI OR RE S HA N OT http://www.consumerreports.org/cro/2012/04/best-health-tests-and-treatments- often-cost-less/index.htmDO
  47. 47. E EM Q AS IR A M R OM F N SIO IS E RM P TEN R IT W OR PRI O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  48. 48. E EM AS Options?? A M IR Q R OM F N IO  Patients share the financial burden burden… IS S RM PE  Financial incentives for physicians and T EN change in the reimbursement system R IT system…. W  Team-based care….RIO R P O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  49. 49. E EM AS Hurdles?? A M IR Q R OM F N IO  Litigation system IS S RM  Transparency (costs, charges,Eetc)N P T TE  Heterogeneity in circumstances RI W R  Anecdotal evidence RIO P O UT H IT W UTE R IB ST DI OR RE S HA NOTDO
  50. 50. E EM AS Recommendations for High- High- IR Q A M V l C -C Value Cost Conscious C Cost- i Care FROM N S IO  Understand the benefits, harms and relative costs of the benefits harms, IS M interventions that you are considering ER P N Decrease or eliminate the use of interventions that provide  T TE no benefits and/or may be harmful RI W  Choose interventions and care O R settings that maximize P RI benefits, minimize harms, and reduce costs (using , T, ( g OU comparative effectiveness and cost effectiveness data) H IT  W Customize a care plan with the patient that incorporates E their valuesIBUT addresses their concerns and R  ST Identify Isystem level opportunities to improve outcomes, D R minimize harms, and reduce healthcare waste O RE S HA NOTDO
  51. 51. E EM Q AS  Issue of the decade starting in 2010: M IR A decreasing the cost of care f OM FR  The rise in health care costs is notSION IS sustainable RM PE  Cost containment measures N happenTE will T RI  Costs can not be controlled unless R W IO Rsubstantially reduced inappropriate care Tis P OU  Why should youHcare about cost? IT W  Physicians y U TE responsible for 87% of spending p p g B RI T  Physicians can be part of the solution or D IS R viewed as part of the problem R E O S HA NOTDO
  52. 52. E EM AS Conserving resources through AMIR Q M providing high value care does N FR Onot IO mean rationing! RM IS S PE  Rationing: decisions are made about the EN T allocation of scarce medical ll ti f diR IT l resources and d W OR who receives them, leading to underuse of PRI potentially appropriate care T H OU IT  Rational or high value care: assuring that E W UT care is clinically effective thus avoiding RI B effective, T overuse D IS or misuse of care that is O R inappropriate AR E SH OT T; Qaseem A et al. Arch Intern Med. 2012 N WiltDO

×